Based on the mutation frequencies, the magnitude of cancer risk, and the influence on clinical management with mutation carriers, the most important breast cancer susceptibility genes include BRCA1, BRCA2, PALB2, and CHEK2 [3,4,5,6,7,8]. This evidence concerns the gene CHEK2 and breast cancer.